Welcome to our dedicated page for Red White Bloom news (Ticker: RWBYF), a resource for investors and traders seeking the latest updates and insights on Red White Bloom stock.
Red White & Bloom Brands Inc. (RWBYF) generates frequent news through its financial reporting, corporate restructuring and expansion activities in the legal cannabis industry. The company’s releases cover its operations as a multi-state and multi-jurisdictional cannabis operator and house of brands active in the United States, Canada and select international jurisdictions.
Investors following RWBYF news will see regular updates on audited annual results and interim financial statements, together with management’s discussion and analysis. These announcements summarize revenues, gross profit, operating expenses, EBITDA and adjusted EBITDA, and often highlight shifts toward higher-margin revenue and changes in the company’s operating structure.
News coverage also focuses on strategic transactions and integration work. A major theme is the acquisition of the former Aleafia group of companies, which expanded Red White & Bloom’s Canadian and international footprint. Releases describe how this transaction added recreational, medical and export channels, as well as cultivation and processing facilities and established brands such as Emblem and Divvy.
Operational updates appear frequently, including commentary on restructuring adult-use and medical-use retail operations in Michigan, receivership proceedings involving Pharmaco Inc., and developments in U.S. markets where the company is active. RWB also reports on licensing and distribution arrangements for its Platinum Vape products in states such as Ohio and Missouri, and on its medical retail and distribution activities in Florida and Michigan.
This news page aggregates these disclosures so readers can review financial performance summaries, regulatory developments, transaction milestones and market-by-market updates for Red White & Bloom Brands Inc. Bookmark this feed to monitor how the company reports on its cannabis operations across North American and select international markets.
Red White & Bloom Brands (RWBYF) filed interim financial statements for the period ended September 30, 2025, including MD&A and CEO/CFO certificates, available on SEDAR+.
The company entered a debt settlement agreement with a former consultant to issue an aggregate of 375,000 common shares at the lesser of the CSE prescribed minimum price of $0.05 per share and the 20-day VWAP as of November 28, 2025, subject to CSE approval. The company anticipates closing the settlement on or about December 8, 2025. Securities will carry a statutory hold period of four months and one day. The release notes the securities are not registered under the U.S. Securities Act and are not being offered in the United States.
Red White & Bloom (OTC:RWBYF) announced it has completed and filed its interim financial statements for the periods ended March 31, 2025 and June 30, 2025, plus related MD&A and CEO/CFO certificates on SEDAR+.
With these filings the company states it has brought its continuous disclosure record up to date, the failure-to-file cease trade order (FFCTO) issued July 3, 2025 by the British Columbia Securities Commission has been revoked, and trading on the Canadian Securities Exchange is expected to resume October 3, 2025.
Red White & Bloom Brands (CSE: RWB) has released its fiscal 2024 financial results, showing mixed performance. The company reported annual revenue of $80.2 million, a significant increase of $10.6 million from 2023. Fourth quarter revenue reached $18.7 million, up by $2.8 million year-over-year.
The company's EBITDA improved substantially to $10.8 million for fiscal 2024, compared to negative $89.0 million in 2023. However, RWB is currently under a failure-to-file cease trade order (FFCTO) due to delayed Q1 2025 filings, which will remain in effect until the company completes these filings and receives regulatory approval.
Red White & Bloom Brands (CSE: RWB) announced that the Michigan Circuit Court has approved a receivership order for its indirect subsidiary Pharmaco's assets. Trust Street Advisors, , through Gene R. Kohut, was appointed as receiver on December 26, 2024. The receivership follows continued defaults under Pharmaco's senior secured loan agreement.
Pharmaco, acquired by RWB in February 2022, operated medical and adult-use retail outlets and cultivation facilities in Michigan. The company's operations no longer align with RWB's core objectives. The receivership is expected to reduce operating expenses, working capital demands, and debt service obligations.
RWB's remaining operations, including Michigan distribution, continue unaffected. The company maintains focus on growth initiatives in Florida, including expanding medical retail presence and enhancing processing and cultivation facilities, while optimizing its Canadian operations.
Red White & Bloom Brands reported significant financial improvements in Q3 2024, with EBITDA increasing twenty-fold to $7.5 million YTD compared to $0.4 million in 2023. Adjusted EBITDA grew 260% to $9.6 million YTD. Revenue reached $21.7 million in Q3, up from $20.1 million in Q3 2023. The company plans to launch five new Florida medical cannabis dispensaries in Q1 2025 and has expanded its Canadian distribution to include Prince Edward Island and New Brunswick. Notable developments include 72 new product listings across provincial distributors and the launch of new cannabis products in California and Florida markets.
Red White & Bloom Brands Inc. (CSE: RWBYF) reported its Q2 2024 financial results, highlighting strategic initiatives and EBITDA growth. Key developments include:
- Advanced refinancing agreements with strategic lenders
- Progressed towards opening five new retail locations in Florida
- Established distribution partnerships in California
- Secured value-added crop commitments in Michigan
- Completed a $5.8 million non-dilutive mortgage financing for Emblem group
The company reported EBITDA of $7.1 million for H1 2024, a year-over-year improvement of over $8 million. RWB is focusing on realigning and strengthening the newly acquired Emblem Cannabis , introducing new product formats, and optimizing operations for sustainable growth.
Red White & Bloom (CSE: RWB) has released its Q1 2024 financial results. Key highlights include a revenue of $22.6 million, an increase of $2.7 million from the previous quarter but a decrease of $3.9 million compared to Q1 2023. Gross profit before fair value adjustments stood at $7.9 million. Operating expenses rose to $12.1 million due to the Aleafia acquisition. EBITDA for the quarter was $5.1 million, a significant improvement from the previous quarter's negative EBITDA. The company completed the Aleafia acquisition in January, leading to operational changes and new product introductions. RWB is focusing on restructuring financing and expanding its retail footprint in Florida while targeting profitable growth.
Red White & Bloom Brands Inc. reports fiscal 2023 annual results with an increase in adjusted EBITDA and gross profit for the second consecutive year. Annual revenue reaches $88.3 million, gross profit at $29.5 million, a 30% increase from the previous fiscal year. Adjusted EBITDA for fiscal 2023 is $5.5 million. The company focuses on higher margin revenue opportunities, restructuring financing arrangements, and expanding into new markets. RWB completes the acquisition of the Aleafia group, positioning itself for potential US federal legalization.
Summary not available.
Summary not available.